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Pleural fluid analysis was performed in patients with idiopathic spontaneous pneumothorax. The objective of the 
study was to define the cell differentiation, and part of the cytokine profile, in relation to the duration of 
pneumothorax. 
In the 23 consecutive patients (19 men, mean age 34.2 years, 17 smokers), pleural fluid was obtained immediately 
after chest tube drainage (n=6), or during thoracoscopy (n= 17). Cytospins were carried out, and supernatant 
analysis of the different cytokines was performed using sandwich ELISA. All concentrations were corrected for 
dilution. 
The duration of the pneumothorax was correlated with the rise in eosinophil percentage (r=O*Sl, P~O.00001) in 
pleural fluid. RANTES, platelet-activating factor (PAF), and monocyte chemotactic protein-l (MCP-1) were 
detectable but no relationship with eosinophils or duration of the pneumothorax was found. Granulocyte- 
macrophage colony stimulating factor (GM-CSF) and interluekin-8 (IL-g) were not detectable. Interleukin-5 (IL-5) 
concentration correlated with the eosinophil concentration (r=0.84, P=O.O37) and the eosinophil percentage 
(r=0.68, P=O.OOS) in the pleural fluid. 
Idiopathic spontaneous pneumothorax causes a time-related rise in the eosinophil percentage in the pleural space, 
which correlates with the level of IL-5. 
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Introduction 
Idiopathic or primary spontaneous pneumothorax (ISP) is 
defined as ‘air in the pleural space, of which the cause is 
unknown’ (1). The normal space between the pleural blades 
is about 20,~m, and contains a low-protein, clear and 
colourless fluid. The pleurae themselves are covered by a 
single layer of mesothelial cells, basement membrane, and 
layers of collagen and elastic tissue. In the caudal part of 
the normal mediastinal pleura, an accumulation of macro- 
phages, pleuripotential mesenchymal cells, lymphoid cells 
and plasma cells surrounding a centric lymphatic channel 
or vessel is found (4). 
Pleural lavage may be a future source of diagnostic yield, 
similar to the present-day bronchoalveolar lavage, but few 
data on the subject are available. 
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To our knowledge, there are no human reference values 
for cell differentiation in the pleural lining fluid. In rabbits, 
32% of the pleural fluid cells were mesothelial cells, 61% 
were mononuclear cells and 7% were lymphocytes (5). 
Normal dog pleural fluid contains 70% mesothelial cells, 
28% mononuclear cells and 2% lymphocytes (6). In 
human pleural fluid following congestive heart failure 
(which is therefore a low-protein fluid), the cell differentia- 
tion consists mainly of lymphocytes and other mono- 
nuclear cells. The number of polymorphonuclear leucocytes 
is small (7). 
Eosinophilic pleural effusion is defined by the presence of 
more than 10% eosinophilic granulocytes (eosinophils) in 
the pleural effusion (1). Although eosinophilic pleural effu- 
sion is a relatively unspecific phenomenon with no clear 
cause, it has especially been associated with blood or air in 
the pleural space (g-10). The pathogenesis of the eosi- 
nophilia, after the entrance of air into the pleural space, is 
unknown. Pleural fluid eosinophilia has been reported 
before in patients with air in the pleural space, but has not 
been related to the time for which the air was present 
(g-10). 
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Several cytokines are related to eosinophilic accumu- 
lation (11,12), such as interleukin-5 (IL-5) (13-15), 
interleukin-3 (IL-3) (13), granulocyte-macrophage colony 
stimulating factor (GM-CSF) (13), eotaxin (16), monocyte 
chemotactic protein-3 (MCP-3) (17) MCP-4 (18,19), mac- 
rophage inflammatory protein (MIP-la) (20), RANTES 
(regulated upon activation in normal T-cells expressed and 
secreted) (20-22), and platelet activating factor (PAF) (23). 
During the past few years the number of cytokines related 
to eosinophilic accumulation has increased rapidly. 
The main aspect of the relationship of eosinophils 
to duration of pneumothorax might be to prevent 
re-expansion pulmonary oedema, as this is also thought to 
be related to the duration of the compressed lung. 
The purpose of this prospective study was to define the 
cell differentiation in relation to the duration of the pneu- 
mothorax (air in the pleural space) in the pleural effusion of 
ISP patients, and to reveal part of its related cytokine 
profile. 
Patients and Methods 
Twenty-three consecutive patients with ISP were included 
in our study, following informed consent, from March 1996 
to March 1997 (19 men, mean f SEM age 34.2 % 1.9 years, 17 
(ex)smokers). The medical ethical committee of the hospital 
approved the study design. In the medical history, the exact 
time and date of the first complaints of the pneumothorax 
were recorded. All patients had an acute and distinct start 
of the symptoms, and could recall the exact date and hour. 
We considered the start of symptoms as the entrance of air 
in the pleural space. After the ISP, the pleural fluid was 
collected during thoracoscopy. All patients underwent this 
thoracoscopy under local anaesthesia, as a routine treat- 
ment modality. Six patients received a chest tube prior to 
the thoracoscopy. In these cases, pleural fluid was also 
collected at the time of the tube insertion. Both samples (via 
chest tube and during thoracoscopy) were compared and 
related to cases without prior drains. The pleural fluid was 
collected undiluted (when possible), or after pleural lavage 
with 30 ml saline 0.9% in cases of insufficient yield. In these 
cases saline was spread out over the pleural surface with a 
syringe and was removed by suction drain. Only the first 
collected samples of the patients were used in the cell and 
cytokine analysis, which means that in six patients the fluid 
was collected via the first chest tube after insertion and in 17 
patients the fluid was collected during the thoracoscopy (in 
which case no prior chest tube was placed). 
On the day of pleural fluid collection, serum urea, 
C-reactive protein, leucocyte count and differentiation, as 
well as eosinophil count, were measured in venous blood. 
Pleural fluid was immediately stored at 4°C. Cytospins 
were performed within 2 h and were stored at - 20°C. The 
supernatant ‘portions were stored at - 80°C. A standard 
May Grtinwald Giemsa staining was performed. Immuno- 
cytochemistry was performed with the alkaline phosphafase 
anti-alkaline phosphatase method (Dakopatt) using the 
following antibodies: Leu4 (anti CD3). THB4 (anti CD21 1, 
EBMl 1 (anti CD68) and BMK13 (anti-eosinophilic major 
basic protein=MBP). 
Supematants were analysed using sandwich ELISA for 
the cytokines in consecutive patients; IL-5 (R&D, detection 
limit 5pgmll’, n=20), IL-8 (PharMingen, detection limit 
50pgml-‘, n= 16 ), MCP-1 (detection limit 30 pg ml - ‘, 
n= 16) RANTES (detection limit 50 pg ml - I, n= 16), 
GM-CSF (PharMingen, detection limit 30 pg ml ~ ‘, n= 16) 
and PAF (RIA, Du Pont, detection limit 0.3 ng ml- ‘, 
n=7). MCP-1 and RANTES ELISA were developed in our 
laboratory (24). 
Because the amount of intrapleural fluid is unknown, 
dilution with poorly mixed 30 ml saline will be impossible 
to estimate. Therefore, only the concentration corrected for 
the dilution factor was used. This was done using the urea 
dilution method (25,26). Because this urea method has not 
been tested for pleural fluid we correlated the serum urea 
with the undiluted pleural fluid urea concentration of 10 
patients with proven pleural exudates (six men/four women; 
two pulmonary embolisms, six malignant pleural effusions, 
two pleuritis without certain diagnosis; lactate dehydro- 
genase, albumen, cholesterol and urea were measured in 
pleural fluid and serum at the same time). This revealed a 
good correlation between blood and pleural fluid urea 
concentrations (r~0.99, P<O.OOOl; paired t-test: not signifi- 
cantly different). We considered the urea dilution method as 
reliable. Only patients with longer existing pneumothoraces 
could deliver undiluted pleural fluid. The concentrations of 
the cytokines and PAF were corrected for the dilution 
factor through use of the serum and pleural fluid urea 
concentrations in the following equation: (ELISA) x [(urea 
in serum)/(urea in pleural fluid)]=end concentration (25). 
The detection limit for urea was 0.08 mmol l- ‘. Because 
of the great difference between samples diluted by saline, 
and undiluted samples, the absolute counts were not con- 
sidered to be useful. The patients were arbitrarily grouped 
in days after the start of symptoms. A delay in treatment of 
up to 3 days (due to the weekend), however, played a role 
here. 
Statistical analysis was performed with linear regression 
analysis in SPSS 6.1 for Windows. 
Results 
The mean cell counts and cell differentiation in the pleural 
fluid samples (corrected for the dilution) and the mean cell 
differentiations are shown in Table 1. 
Fig. 1 shows the time-related rise in the percentage of 
eosinophils in relation to the other cells found in the pleural 
fluid (r=0.81, P<O.OOOOl). Cells present on the first day 
after contracting the pneumothorax are predominantly 
macrophages and neutrophils. On days 4-7, the eosinophil 
count was higher than that of all other cells. The neutrophil 
concentration showed a minor increase over time. 
In six patients, a chest tube was introduced prior to the 
thoracoscopy. The samples taken at the time of the chest 
tube introduction and those taken following thoracoscopy 
were compared to ensure that no differences were caused by 
the different sampling method. We found no difference in 
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TABLE 1. Cell differentiation in pleural fluid related to the duration of pneumothorax 
Cells 
Days after onset of ISP Day O-l Day l-3 
Mean (SEM) 
Day 4-7 Day ~7 All 
Patients (n) 10 3 6 4 23 
Neutrophils (%) 50.7 (8.4) 37.2 (145) 18.5 (13.2) 3.3 (1.7) 32.3 (6.4) 
Basophils (%) 0 0.4 (0.3) 1.7 (1.0) 1.6 (1.2) 0.8 (0.4) 
Mesothelial cells (%) 0.3 (0.3) 4.3 (3.4) 0.2 (0.2) 3.9 (3.9) 1.4 (0.8) 
T cells (%) (CD2/3+) 3.4 (2.2) 6.3 (3.4) 11.7 (4.3) 7.9 (35) 6.7 (1.7) 
Macrophages (%) (CD68+) 41.8 (7.5) 32.4 (12.5) 25.8 (10.2) 19.4 (14.7) 32.5 (5.17) 
Eosinophils (%) 3.1 (1.1) 19.4 (6.6) 42.5 (12.6) 63.7 (11.3) 26.1 (6.2) 
Eosinophils x lo6 1 - ’ 0.7 (0.4) 9.2 (7.0) 7.9 (2.4) 4.3 (1.6) 4.0 (1.1) 
WBC x lo7 l- ’ 2.5 (1.3) 7.5 (5.9) 1.2 (0.3) 0.8 (0.4) 2.5 (0.9) 
The start of the pneumothorax is defined as the start of the symptoms. 
WBC=absolute white blood cell count corrected for dilution; T cell=lymphocyte. 
cell differentiation in samples taken at the same time via 
primary chest tube or primary thoracoscopy (0.23<P<O.9; 
two-tailed t-test). However, we did not use any samples of 
pleural fluid when a chest tube had already been present for 
some time, because of the theoretical mechanical damage to 
the pleurae caused by the chest tube. 
Table 2 shows the mean concentrations of the cytokines 
in the different time cohorts. GM-CSF and IL-8 could not 
be detected. MCP-1, RANTES and PAF were detectable. 
The values were corrected for the dilution by use of the 
described urea concentration method. No correlation with 
the duration of the pneumothorax was found for MCP-1, 
RANTES and PAF. PAF (n=7) was only detectable in the 
lower regions of the assay (e1.7 ngml- ‘). The mean 
concentration of PAF was 0.29 pg ml - ’ ( & SEM 0.11). PAF 
was not related to the cell indices, nor to chest tube 
drainage. IL-5 correlated with the eosinophil concentration 
(r=0.84, P=O.O37) from 24 h onwards. IL-5 also correlated 
with the percentage of eosinophils in the cell differentiation 
(rc0.68, P=O.OOS). The correlation between the duration of 
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FIG. 1. Cell differentiation in. pleural fluid after spon- 
taneous pneumothorax; a time-related rise in eosinophils 
(0, eosinophils; -, neutrophils; _.- -, lymphocytes; 
. . ., macrophages). 
the pneumothorax, and log IL-5 was not significant 
(r=0.17, P=O.O6). The IL-5 concentration rose following 
the start of the pneumothorax complaints (trend: r=0.48, 
P=O.O69). 
No elevations of C-reactive protein, leucocytes or eosino- 
phi1 concentration (or percentage) in the serum were found 
at time of the pleural fluid sampling (data not shown). 
Discussion 
In ISP patients, by definition, there is air in the pleural 
space without any known underlying disease (1). ISP 
patients are usually able to define the exact time of con- 
tracting the pneumothorax because of the pleural pain 
accompanying the event. Our routine treatment of ISP 
(including the first event) is aimed at preventing recurrence, 
therefore a thoracoscopy under local anaesthesia is per- 
formed with talc pleurodesis. This routine approach makes 
it possible to investigate the pleural fluid of all referred ISP 
patients. Whether pleural fluid aspirated shortly after con- 
tracting the ISP is comparable to normal pleural fluid is not 
known because of the lack of reference values to normal 
human pleural fluid. 
In rabbits and dogs, mesothelial and mononuclear cells 
are most common in the cell differentiation of normal 
pleural fluid (5,6). In the first 24 h after the start of the ISP 
in our study, we found predominantly macrophages and 
neutrophils and few mesothelial cells. 
Our results show a clear relationship between the rise in 
the number (percentage) of eosinophils in the pleural fluid 
samples and the time after the start of the ISP (Fig. 1). To 
our knowledge, no systematic time-related rise in eosi- 
nophils in human pleural fluid has been previously 
described but the relationship between air and eosinophils 
in the pleura space has been reported (8-10). The 
pathogenesis is unknown. 
Eosinophilic pleural effusion has been described in many 
diseases and is thought to be unspecific in relation to its 
cause. 
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TABLE 2. Supernatant cytokine analysis of pleural fluid at different times after the start of the first 
symptoms of the pneumothorax 
Cytokines 
Days after onset of ISP Day O-l Day 1-3 
Mean (SEM) 
Day 4-7 Day >7 All 
IL-5 (pg ml - ‘) (n = 20) 2.1 (2.1) 70.3 (60.3) 29.5 (26.4) 63.4 (32.2) 28.4 (4.5) 
RANTES (ng ml - ‘) (n = 16) 0.7 (0.3) <LD 3.7 (2.4) 0.6 (0.4) 0.5 (3.0) 
MCP-1 (ngml-‘) (n=16) 6.6 (45) 0.9 (0.1) 0.5 (0.2) 1.2 (0.3) 3.4 (3.0) 
GM-CSF (n= 16) <LD <LD <LD <LD <LD 
IL-8 (n= 16) <LD <LD <LD <LD <LD 
Concentrations were corrected for dilution. 
IL=interleukin; RANTES=regulated upon activation in normal T cells expressed and secreted; 
MCP=monocyte chemotactic protein; GM-CSF=granulocyte/macrophage colony stimulating 
factor; <LD=less than the limit of detection of the assay. 
Whether the rise in eosinophils is causally related to the involved in the eosinophil chemotaxis. Eosinophils them- 
pathogenesis of the pneumothorax is unclear. As eosi- selves, however, may also be a source of IL-5 (13). It is 
nophils are not present immediately after contracting the therefore unclear whether IL-5 is the cause or the result of 
pneumothorax, we do not believe that there is a causal eosinophil accumulation. In the literature, PAF, GM-CSF 
relationship but consider them to be a consequence of air in and II-5 were shown to be important for the eosinophilic 
the pleural cavity. Eosinophils may be important in the accumulation in the pleural cavity (13,23,28). We could not 
natural healing process of the spontaneous pneumothorax detect GM-CSF in either the diluted or the undiluted 
by inducing inflammation. sample. 
The rise in eosinophils is preceded by a high percentage 
of macrophages and neutrophils, which is an unusual 
beginning to the inflammatory process. In most inflamma- 
tory processes, neutrophilia is followed by mononuclear 
influx and the cause of the relatively high percentage of 
macrophages in the initial phase of pneumothorax is 
unclear. In a normal physiological situation, macrophages 
may already have been present before the pneumothorax 
occurred, or may have been present due to a prolonged 
inflammatory proces in the pleural space, and related to the 
inflammatory process present in the distal parts of the lung 
in patients with ISP. 
PAF is probably not involved, at least not in the pleural 
fluid, as the concentrations were lo-fold or more below the 
working range of the in vitro chemotactic assays (between 
10 and 100 nmol). 
RANTES has been reported to be involved, as an 
eosinophil chemoattractant (20-22). In our data, half of the 
consecutive samples had detectable RANTES, but with no 
significant relationship to the amounts of the different 
cells, the cell differentiation, or the duration of the 
pneumothorax. 
In six cases, thoracoscopic sampling of pleural effusions 
was preceeded by chest tube insertion l-3 days before. 
Analysis of the cells and cytokines revealed no differences 
between the patients with or without previous chest tube 
drainage in relation to the duration of the pneumothorax. 
Serial follow-up of these patients, i.e. two data points per 
patient, fits to the data we present here, although it was not 
included in the study design. We conclude that the chest 
tube did not influence the eosinophilic inflammatory 
process. 
Anthony et al. detected IL-8 in pleural fluids of patients 
with malignant pleural effusion (29). IL-8 could be 
measured in samples of pleural fluid after talcage (26), but 
not in the pleural fluid where air has been the only 
‘irritating’ factor in the pleural space, despite the fact that 
this inflammatory process starts with a high percentage of 
neutrophils and macrophages. Therefore, another chemo- 
kine may be involved in the neutrophil accumulation in the 
first days after the presence of air. 
Several cytokines and chemokines are implicated in 
eosinophil accumulation. It has been suggested that lym- 
phocytes are important in the accumulation process of 
eosinophils in the pleural cavity (27). Schandene described 
three patients with post-traumatic pneumothoraces, in 
whom CD4+ T-cells were responsible for IL-5 production 
(14). In our study, however, T lymphocytes are only a 
minor population, suggesting that they were not involved in 
IL-5 production. 
MCP-1 was measurable in 14 of the 16 samples of ISP 
patients with different durations of pneumothorax. MCP-1 
has been described as stimulating monocyte recruitment, 
especially in malignant pleural effusions (29). We could not 
detect a relationship with the absolute amount of mono- 
cytes, nor with the percentage of monocytes in the cell 
differentiation. 
A significant correlation was found between the eosino- 
phi1 and IL-5 concentration, suggesting that IL-5 is 
Several chemokines are thus shown to be detectable 
in the pleural fluids of ISP patients, which may give 
some direction to the pathogenesis of the pleural 
eosinophilia in case of air in the -pleural space (in 
ISP patients). IL-5 was the only cytokine related to 
eosinophils. None of the other tested chemokines 
were related to the cell indices, which suggests that 
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other chemokines are involved in the inflammatory process 
in the pleural cavity. 
The spontaneous pneumothorax patient who will 
undergo thoracoscopy seems to provide a good model for 
the investigation of eosinophilic pleural effusion. Future 
studies may include parietal and, when possible, visceral 
pleural biopsies to reveal more of the pathogenesis of this 
‘unusual’ form of inflammation. For the daily practice, the 
detection of an eosinophilic effusion in a patient with ISP 
may be an indication of prolonged collapse of the lung. 
This can be important because rapid expansion of the lung 
might be followed by re-expansion oedema in these patients 
(30,31). 
Conclusions 
Human idiopathic spontaneous pneumothorax with air in 
the pleural cavity results in a time-related rise in the 
percentage of eosinophils in the pleural fluid. The eosino- 
phi1 accumulation after 24-72 h follows an initial high 
percentage of neutrophils and macrophages. MCP-1, PAF 
and RANTES were detectable, but were not related 
to the duration of the pneumothorax, nor to cell indices. 
IL-5 correlates with the eosinophil concentration and 
percentage. 
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